Masters in Therapeutic Oncology Summit: Lung Edition (MaTOS Lung) is a dynamic 3-day conference led by experts in thoracic oncology. This summit delivers in-depth, multidisciplinary discussions on the most pressing challenges and future directions in lung cancer care. Participants will explore cutting-edge advances in molecular profiling, immunotherapy, targeted therapy, liquid biopsies & minimal residual disease (MRD), and emerging technologies in screening, tumor monitoring and therapy. Engaging panel sessions and case-based dialogues will emphasize the integration of new data into current standards of care, including the classification and clinical application of adjuvant and neoadjuvant therapies. Attendees will leave with actionable insights that can immediately inform their practice and improve patient outcomes. Key points will include: Emerging therapeutic strategies in thoracic oncology, including targeted agents and immunotherapies Implementation of lung cancer screening programs using imaging, liquid biopsies, and novel biomarkers Multidisciplinary evaluation of new clinical data and its integration into treatment pathways Critical appraisal of newly approved agents and evolving standards in metastatic and early-stage disease

Thank you for attending this conference.  Your feedback is valuable to us.

To receive your Certificate of Attendance, complete and submit the Evaluation Form. Once this form is submitted your certificate will be available for download.

Registered attendees can earn a maximum of 13.25 CME credits. You will be able to select the amount of credits being claimed.

For questions regarding credit for this activity, please contact MEC at info@meccinc.com. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.